$ cat ./records/gates-foundation-co-funds-who-mrna-technology-transfer-hub-in-sou-2021.txt
Gates Foundation Co-Funds WHO mRNA Technology Transfer Hub in South Africa
[RECORD.TXT] · cat --full
The Gates Foundation was among the founding funders of the WHO mRNA Technology Transfer Hub at Afrigen Biologics and Vaccines in Cape Town, South Africa, launched in June 2021. The hub provides low- and middle-income country manufacturers with the mRNA technology, know-how, and materials to produce COVID-19 and future mRNA vaccines independently. Recipient manufacturers in Argentina, Bangladesh, Egypt, Indonesia, Nigeria, Pakistan, Serbia, Tunisia, and Vietnam received transfers, representing the first movement of mRNA vaccine manufacturing capability to the global south at scale.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Bill Gates Advocates 100% Synthetic Beef for Rich Countries in 'How to Avoid a Climate Disaster'
Next →
Gates-Backed World Mosquito Program Yogyakarta RCT Shows 77% Dengue Reduction in New England Journal of Medicine
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.